✦ LIBER ✦

Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinoma

✍ Scribed by B. PIURA; A. RABINOVICH

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly topotecan in heavily pretreated p

✍ David M. O'Malley; Masoud Azodi; Anita Makkenchery; Jacob Tangir; Jessica McAlpi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase II evaluation of topotecan and nav

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall K. Gibb; Lynne Lipp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Salvage therapy with topotecan in heavil

✍ Lubomir Bodnar; Gabriel Wcislo; Anna Nasilowska; Katarzyna Szarlej-Wcislo; Agnie 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 314 KB

Topotecan in patients with BRCA-associat

✍ David M. Hyman; Qin Zhou; Angela G. Arnold; Rachel N. Grisham; Alexia Iasonos; N 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Weekly topotecan in a heavily pretreated

✍ J. Evans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Timing of genetic counselling in patient

✍ Novetsky, A.; Smith, K.; Babb, S.; Jeffe, D.; Hagemann, A.; Thaker, P.; Powell, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB